Search research articles
Contact Us
Filters
Showing results (81-90 of 157) with videos related to
Page
of 16
Sort By:
Pediatric Blood & Cancer
|
April 18, 2023
Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Timothy B Lautz, Wei Xue, Leo Y Luo, et al.
Cancers
|
May 16, 2023
Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma
Adam P Yan, Rajkumar Venkatramani, Julie A Bradley, et al.
Pediatric Blood & Cancer
|
April 12, 2021
Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
Jennifer H Foster, Andrew Sher, Victor Seghers, et al.
Cancer
|
March 1, 2023
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group
Jonathan Metts, Wei Xue, Zhengya Gao, et al.
The Journal of Surgical Research
|
December 8, 2019
Global Disparities in Wilms Tumor
Megan E Cunningham, Theodore D Klug, Jed G Nuchtern, et al.
Pediatric Blood & Cancer
|
March 4, 2011
Supratentorial ependymoma in children: to observe or to treat following gross total resection?
Rajkumar Venkatramani, Girish Dhall, Moneil Patel, et al.
Pediatric Blood & Cancer
|
March 31, 2026
Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 months) Treated on the Prior Children's Oncology Group Protocol ARST1431
Katrina Winsnes, Julie A Bradley, Zhengya Gao, et al.
La Radiologia Medica
|
March 5, 2026
Do skeletal muscle bulk and density affect survival outcome in pediatric patients with rhabdomyosarcoma?
Rida Salman, Esther Ngan, Zbigniew A Starosolski, et al.
Pediatric Blood & Cancer
|
April 6, 2017
Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III
Kenneth K Wong, Sean All, Jonathan Waxer, et al.
Cancer Medicine
|
April 4, 2023
Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis
Wendy Allen-Rhoades, Philip J Lupo, Michael E Scheurer, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 157) with videos related to
Sort By:
Page
of 16
Pediatric Blood & Cancer
|
April 18, 2023
Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Timothy B Lautz, Wei Xue, Leo Y Luo, et al.
Cancers
|
May 16, 2023
Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma
Adam P Yan, Rajkumar Venkatramani, Julie A Bradley, et al.
Pediatric Blood & Cancer
|
April 12, 2021
Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
Jennifer H Foster, Andrew Sher, Victor Seghers, et al.
Cancer
|
March 1, 2023
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group
Jonathan Metts, Wei Xue, Zhengya Gao, et al.
The Journal of Surgical Research
|
December 8, 2019
Global Disparities in Wilms Tumor
Megan E Cunningham, Theodore D Klug, Jed G Nuchtern, et al.
Pediatric Blood & Cancer
|
March 4, 2011
Supratentorial ependymoma in children: to observe or to treat following gross total resection?
Rajkumar Venkatramani, Girish Dhall, Moneil Patel, et al.
Pediatric Blood & Cancer
|
March 31, 2026
Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 months) Treated on the Prior Children's Oncology Group Protocol ARST1431
Katrina Winsnes, Julie A Bradley, Zhengya Gao, et al.
La Radiologia Medica
|
March 5, 2026
Do skeletal muscle bulk and density affect survival outcome in pediatric patients with rhabdomyosarcoma?
Rida Salman, Esther Ngan, Zbigniew A Starosolski, et al.
Pediatric Blood & Cancer
|
April 6, 2017
Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III
Kenneth K Wong, Sean All, Jonathan Waxer, et al.
Cancer Medicine
|
April 4, 2023
Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis
Wendy Allen-Rhoades, Philip J Lupo, Michael E Scheurer, et al.
Page
of 16